Journal of Behavioral Medicine

, Volume 40, Issue 4, pp 553–564 | Cite as

How people think about the chemicals in cigarette smoke: a systematic review

  • Jennifer C. Morgan
  • M. Justin Byron
  • Sabeeh A. Baig
  • Irina Stepanov
  • Noel T. Brewer
Article

Abstract

Laws and treaties compel countries to inform the public about harmful chemicals (constituents) in cigarette smoke. To encourage relevant research by behavioral scientists, we provide a primer on cigarette smoke toxicology and summarize research on how the public thinks about cigarette smoke chemicals. We systematically searched PubMed in July 2016 and reviewed citations from included articles. Four central findings emerged across 46 articles that met inclusion criteria. First, people were familiar with very few chemicals in cigarette smoke. Second, people knew little about cigarette additives, assumed harmful chemicals are added during manufacturing, and perceived cigarettes without additives to be less harmful. Third, people wanted more information about constituents. Finally, well-presented chemical information increased knowledge and awareness and may change behavior. This research area is in urgent need of behavioral science. Future research should investigate whether educating the public about these chemicals increases risk perceptions and quitting.

Keywords

Tobacco Constituents Chemicals Ingredients Additives Communication 

Supplementary material

10865_2017_9823_MOESM1_ESM.xlsx (45 kb)
Supplementary material 1 (XLSX 45 kb)

References

  1. Arnett, J. J. (1999). Winston’s” No Additives” campaign:” straight up”?” no bull”? Public Health Reports, 114, 522.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bansal, M. A., Cummings, K. M., Hyland, A., Bauer, J. E., Hastrup, J. L., & Steger, C. (2004a). Do smokers want to know more about the cigarettes they smoke? Results from the EDUCATE study. Nicotine & Tobacco Research, 6, S289–S302. doi:10.1080/14622200412331320699 CrossRefGoogle Scholar
  3. Bansal, M. A., Cummings, K. M., Hyland, A., & Giovino, G. A. (2004b). Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? Nicotine & Tobacco Research, 6, S303–S310. doi:10.1080/14622200412331320707 CrossRefGoogle Scholar
  4. Bansal-Travers, M., Cummings, K. M., Hyland, A., Brown, A., & Celestino, P. (2010). Educating smokers about their cigarettes and nicotine medications. Health Education Research, 25, 678–686. doi:10.1093/her/cyp069 CrossRefPubMedPubMedCentralGoogle Scholar
  5. Benowitz, N. L. (2001). Compensatory smoking of low-yield cigarettes. In D. R. Shopland (Ed.), Risks associated with smoking cigarettes with low machine yields of tar and nicotine (pp. 39–63). Rockville, MD: U.S. Department of Health and Human Services.Google Scholar
  6. Benowitz, N. L. (2003). Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment. Progress in Cardiovascular Diseases, 46, 91–111. doi:10.1016/S0033-0620(03)00087-2 CrossRefPubMedGoogle Scholar
  7. Berman, M. L., Byron, M. J., Hemmerich, N., Lindblom, E. N., Lazard, A. J., Peters, E., & Brewer, N. T. (in press). Communicating tobacco product information to the public. Food and Drug Law Journal.Google Scholar
  8. Biener, L., Nyman, A. L., Stepanov, I., & Hatsukami, D. (2014). Public education about the relative harm of tobacco products: An intervention for tobacco control professionals. Tobacco Control, 23, 385–388. doi:10.1136/tobaccocontrol-2012-050814 CrossRefPubMedGoogle Scholar
  9. Borgida, E., Loken, B., Williams, A. L., Vitriol, J., Stepanov, I., & Hatsukami, D. (2015). Assessing constituent levels in smokeless tobacco products: A new approach to engaging and educating the public. Nicotine & Tobacco Research, 17, 1354–1361. doi:10.1093/ntr/ntv007 CrossRefGoogle Scholar
  10. Borland, R., & Hill, D. (1997). Initial impact of the new Australian tobacco health warnings on knowledge and beliefs. Tobacco Control, 6, 317–325.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Borrelli, B., & Novak, S. P. (2007). Nurses’ knowledge about the risk of light cigarettes and other tobacco “harm reduction” strategies. Nicotine & Tobacco Research, 9, 653–661. doi:10.1080/14622200701365202 CrossRefGoogle Scholar
  12. Bostrom, A., Fischhoff, B., & Morgan, M. G. (1992). Characterizing mental models of hazardous processes: A methodology and an application to radon. Journal of Social Issues, 48, 85–100. doi:10.1111/j.1540-4560.1992.tb01946.x CrossRefGoogle Scholar
  13. Boynton, M. H., Agans, R. P., Bowling, J. M., Brewer, N. T., Sutfin, E. L., Goldstein, A. O., et al. (2016). Understanding how perceptions of tobacco constituents and the FDA relate to effective and credible tobacco risk messaging: A national phone survey of U.S. adults, 2014–2015. BMC Public Health, 16, 516. doi:10.1186/s12889-016-3151-5 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Brewer, N. T., Morgan, J. C., Baig, S. A., Mendel, J. R., Boynton, M. H., Pepper, J. K., et al. (2016). Public understanding of cigarette smoke constituents: Three United States surveys. Tobacco Control. doi:10.1136/tobaccocontrol-2015-052897 Google Scholar
  15. Carter, S. M., & Chapman, S. (2006). Smokers and non-smokers talk about regulatory options in tobacco control. Tobacco Control, 15, 398–404.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Chaaya, M., Jabbour, S., El-Roueiheb, Z., & Chemaitelly, H. (2004). Knowledge, attitudes, and practices of argileh (water pipe or hubble-bubble) and cigarette smoking among pregnant women in Lebanon. Addictive Behaviors, 29, 1821–1831. doi:10.1016/j.addbeh.2004.04.008 CrossRefPubMedGoogle Scholar
  17. Cohen, J. B. (1996). Smokers’ knowledge and understanding of advertised tar numbers: Health policy implications. American Journal of Public Health, 86, 18–24. doi:10.2105/ajph.86.1.18 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Counts, M., Hsu, F., Laffoon, S., Dwyer, R., & Cox, R. (2004). Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regulatory Toxicology and Pharmacology, 39, 111–134.CrossRefPubMedGoogle Scholar
  19. Crawford, M. A., Balch, G. I., & Mermelstein, R. (2002). Responses to tobacco control policies among youth. Tobacco Control, 11, 14–19.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Cummings, K. M., Hyland, A., Bansal, M. A., & Giovino, G. A. (2004a). What do Marlboro Lights smokers know about low-tar cigarettes? Nicotine & Tobacco Research, 6, S323–S332. doi:10.1080/14622200412331320725 CrossRefGoogle Scholar
  21. Cummings, K. M., Hyland, A., Giovino, G. A., Hastrup, J. L., Bauer, J. E., & Bansal, M. A. (2004b). Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine & Tobacco Research, 6, S333–S340. doi:10.1080/14622200412331320734 CrossRefGoogle Scholar
  22. Czoli, C. D., & Hammond, D. (2014). Cigarette packaging: Youth perceptions of “natural” cigarettes, filter references, and contraband tobacco. Journal of Adolescent Health, 54, 33–39. doi:10.1016/j.jadohealth.2013.07.016 CrossRefPubMedGoogle Scholar
  23. Ding, Y. S., Ashley, D. L., & Watson, C. H. (2007). Determination of 10 carcinogenic polycyclic aromatic hydrocarbons in mainstream cigarette smoke. Journal of Agricultural and Food Chemistry, 55, 5966–5973.CrossRefPubMedGoogle Scholar
  24. Djordjevic, M. V., Stellman, S. D., & Zang, E. (2000). Doses of nicotine and lung carcinogens delivered to cigarette smokers. Journal of the National Cancer Institute, 92, 106–111.CrossRefPubMedGoogle Scholar
  25. Downs, J. S., de Bruin, W. B., & Fischhoff, B. (2008). Parents’ vaccination comprehension and decisions. Vaccine, 26, 1595–1607.CrossRefPubMedGoogle Scholar
  26. Environics Research Group. (1996a). Public attitudes toward toxic constituent labelling on cigarette packages: Qualitative research report. Ottawa, Ontario: Health Canada.Google Scholar
  27. Environics Research Group. (1996b). Public attitudes toward the listing of toxic ingredients on cigarette packages: A survey report. Ottawa, Ontario: Health Canada.Google Scholar
  28. Environics Research Group. (2003a). Summary report of four focus groups in Toronto & Montréal on awareness and understanding on toxic emissions information on tobacco packaging: Final report. Ottawa, Ontario: Health Canada.Google Scholar
  29. Environics Research Group. (2003b). Toxics information on cigarette packaging: Results of a survey of smokers. Ottawa, Ontario: Health Canada.Google Scholar
  30. Etter, J. F. (2007). Informing smokers on additives in cigarettes: A randomized trial. Patient Education and Counseling, 66, 188–191. doi:10.1016/j.pec.2006.12.001 CrossRefPubMedGoogle Scholar
  31. Etter, J. F., Kozlowski, L. T., & Perneger, T. V. (2003). What smokers believe about light and ultralight cigarettes. Preventive Medicine, 36, 92–98.CrossRefPubMedGoogle Scholar
  32. Family Smoking Prevention and Tobacco Control Act (2009). Public Law 111–31 [H.R. 1256].Google Scholar
  33. Fathelrahman, A. I., Omar, M., Awang, R., Cummings, K. M., Borland, R., & Samin, A. S. B. M. (2010). Impact of the new Malaysian cigarette pack warnings on smokers’ awareness of health risks and interest in quitting smoking. International Journal of Environmental Research and Public Health, 7, 4089–4099. doi:10.3390/ijerph7114089 CrossRefPubMedPubMedCentralGoogle Scholar
  34. Feng, Z., Hu, W., Hu, Y., & Tang, M.-S. (2006). Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proceedings of the National Academy of Sciences, 103, 15404–15409. doi:10.1073/pnas.0607031103 CrossRefGoogle Scholar
  35. Fischhoff, B., Slovic, P., & Lichtenstein, S. (1982). Lay foibles and expert fables in judgments about risk. The American Statistician, 36, 240–255.Google Scholar
  36. Framework Convention on Tobacco Control. (2003). The World Health Organization. Retrieved from http://www.who.int/gb/fctc/PDF/inb6/einb65.pdf
  37. Gallopel-Morvan, K., Moodie, C., Hammond, D., Eker, F., Beguinot, E., & Martinet, Y. (2011). Consumer understanding of cigarette emission labelling. European Journal of Public Health, 21, 373–375. doi:10.1093/eurpub/ckq087 CrossRefPubMedGoogle Scholar
  38. Gilpin, E. A., Emery, S., White, M. M., & Pierce, J. P. (2002). Does tobacco industry marketing of ‘light’cigarettes give smokers a rationale for postponing quitting? Nicotine & Tobacco Research, 4, S147–S155.CrossRefGoogle Scholar
  39. Gori, G. B. (1990). Consumer perception of cigarette yields: Is the message relevant? Regulatory Toxicology and Pharmacology, 12, 64–68. doi:10.1016/s0273-2300(05)80047-9 CrossRefPubMedGoogle Scholar
  40. Hall, M. G., Ribisl, K. M., & Brewer, N. T. (2014). Smokers’ and nonsmokers’ beliefs about harmful tobacco constituents: Implications for FDA communication efforts. Nicotine & Tobacco Research, 16, 343–350. doi:10.1093/ntr/ntt158 CrossRefGoogle Scholar
  41. Hammond, D., Fong, G., McNeill, A., Borland, R., & Cummings, K. M. (2006). Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: Findings from the International Tobacco Control (ITC) Four Country Survey. Tobacco Control, 15, iii19–iii25.CrossRefPubMedPubMedCentralGoogle Scholar
  42. Hammond, D., & White, C. M. (2012). Improper disclosure: Tobacco packaging and emission labelling regulations. Public Health, 126, 613–619. doi:10.1016/j.puhe.2012.03.012 CrossRefPubMedGoogle Scholar
  43. Hassan, L. M., & Shiu, E. (2013). No place to hide: Two pilot studies assessing the effectiveness of adding a health warning to the cigarette stick. Tobacco Control. doi:10.1136/tobaccocontrol-2013-051238 PubMedGoogle Scholar
  44. Hecht, S. S. (1998). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chemical Research in Toxicology, 11, 559–603. doi:10.1021/tx980005y CrossRefPubMedGoogle Scholar
  45. Hecht, S. S. (1999). Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute, 91, 1194–1210.CrossRefPubMedGoogle Scholar
  46. Hecht, S. S. (2003). Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews Cancer, 3, 733–744.CrossRefPubMedGoogle Scholar
  47. Hecht, S. S. (2012). Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control Act. Nicotine & Tobacco Research, 14, 18–28.CrossRefGoogle Scholar
  48. Hecht, S. S., Chen, C., Dong, M., Ornaf, R. M., Hoffmann, D., & Tso, T. (1977). Chemical studies on tobacco smoke: LI: Studies on non-volatile nitrosamines in tobacco. Beiträge zur Tabakforschung/Contributions to Tobacco Research, 9, 1–6. doi:10.2478/cttr-2013-0419 CrossRefGoogle Scholar
  49. Hoffmann, D., Hecht, S. S., Ornaf, R. M., Wynder, E. L., & Tso, T. C. (1976). Chemical studies on tobacco smoke. XLII. Nitrosonornicotine: Presence in tobacco, formation and carcinogenicity. IARC Scientific Publication, 14, 307–320.Google Scholar
  50. Hoffmann, D., Hoffmann, I., & El-Bayoumy, K. (2001). The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chemical Research in Toxicology, 14, 767–790.CrossRefPubMedGoogle Scholar
  51. Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005). Metabolism and disposition kinetics of nicotine. Pharmacological Reviews, 57, 79–115.CrossRefPubMedGoogle Scholar
  52. International Agency for Research on Cancer. (1995). Dry cleaning, some chlorinated solvents and other industrial chemicals. In IARC monographs on the evaluation of carcinogenic risks to humans, 63.Google Scholar
  53. International Agency for Research on Cancer. (1999). Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. In IARC monographs on the evaluation of carcinogenic risks to humans, 71.Google Scholar
  54. International Agency for Research on Cancer. (2004). Tobacco smoke and involuntary smoking. In IARC monographs on the evaluation of carcinogenic risks to humans, 83.Google Scholar
  55. International Agency for Research on Cancer. (2007). Smokeless tobacco and some tobacco-specific N-nitrosamines. In IARC monographs on the evaluation of carcinogenic risks to humans, 89.Google Scholar
  56. International Agency for Research on Cancer. (2010a). Some aromatic amines, organic dyes, and related exposures. In IARC monographs on the evaluation of carcinogenic risks to humans, 99.Google Scholar
  57. International Agency for Research on Cancer. (2010b). Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. In IARC monographs on the evaluation of carcinogenic risks to humans, 92.Google Scholar
  58. International Agency for Research on Cancer. (2012a). Arsenic, metals, fibres, and dusts. In IARC monographs on the evaluation of carcinogenic risks to humans, 100C.Google Scholar
  59. International Agency for Research on Cancer. (2012b). Chemical agents and related occupations. In IARC monographs on the evaluation of carcinogenic risks to humans, 100F.Google Scholar
  60. Ipsos-Eureka. (2009). Public health value of disclosed cigarette ingredients and emissions data. Phillip: Department of Health and Ageing.Google Scholar
  61. Kelley, D. E., Boynton, M., Noar, S. M., Morgan, J., Mendel, J., Ribisl, K. M., & Brewer, N. T. (2016). Identifying effective elements for disclosure messages about harmful constituents. Poster session presented at the 37th Annual Meeting of the Society of Behavioral Medicine, Washington, D.C.Google Scholar
  62. Kelly, K. J., & Manning, K. (2014). The effects of natural cigarette claims on adolescents’ brand-related beliefs, attitudes, and intentions. Journal of Health Communication, 19, 1064–1075. doi:10.1080/10810730.2013.872720 CrossRefPubMedGoogle Scholar
  63. Lewandowsky, S., Ecker, U. K., Seifert, C. M., Schwarz, N., & Cook, J. (2012). Misinformation and its correction continued influence and successful debiasing. Psychological Science in the Public Interest, 13, 106–131.CrossRefPubMedGoogle Scholar
  64. Maharik, M., & Fischhoff, B. (1992). The risks of using nuclear energy sources in space: Some lay activists’ perceptions. Risk Analysis, 12, 383–392.CrossRefGoogle Scholar
  65. McDaniel, P. A., & Malone, R. E. (2007). “I always thought they were all pure tobacco”: American smokers’ perceptions of “natural” cigarettes and tobacco industry advertising strategies. Tobacco Control, 16, e7. doi:10.1136/tc.2006.019638 CrossRefPubMedPubMedCentralGoogle Scholar
  66. Mooney, M. E., Leventhal, A. M., & Hatsukami, D. K. (2006). Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine & Tobacco Research, 8, 435–446. doi:10.1080/14622200600670397 CrossRefGoogle Scholar
  67. Moracco, K. E., Morgan, J. C., Mendel, J., Teal, R., Noar, S. M., Ribisl, K. M., et al. (2016). “My first thought was croutons:” Perceptions of cigarettes and cigarette smoke constituents among adult smokers and nonsmokers. Nicotine & Tobacco Research, 18, 1566–1574. doi:10.1093/ntr/ntv281 CrossRefGoogle Scholar
  68. Mullins, R., & Borland, R. (1992). Evaluation of the what’s your poison? campaign. In R. Mullins (Ed.), Quit evaluation studies (Vol. 6). Melbourne: Anti-Cancer Council of Victoria.Google Scholar
  69. National Research Council of the National Academies. (2008). Combined exposures to hydrogen cyanide and carbon monoxide in Army operations: Initial report. Retrieved from Washington (DC)Google Scholar
  70. Noar, S. M., Kelley, D. E., Boynton, M., Morgan, J., Hall, M., Mendel, J., Ribisl, K. M., & Brewer, N. T. (2016). Perceived effectiveness of cigarette pack constituent disclosures: A randomized experiment. Poster session presented at the 22nd Annual Meeting of the Society for Research on Nicotine and Tobacco, Chicago, IL.Google Scholar
  71. O’connor, R. J., Kozlowski, L. T., Borland, R., Hammond, D., & McNeill, A. (2006). Relationship between constituent labelling and reporting of tar yields among smokers in four countries. Journal of Public Health, 28, 324–329. doi:10.1093/pubmed/fdl056 CrossRefPubMedGoogle Scholar
  72. Osman, A., Thrasher, J. F., Arillo-Santillan, E., & Regalado-Pineda, J. (2013). Cigarette-pack warnings, knowledge about tobacco constituents, and quit behavior: A population-based longitudinal study of Mexican smokers. Paper presented at the Society for Research on Nicotine and Tobacco, Boston, MA.Google Scholar
  73. Osman, A., Thrasher, J. F., Cayir, E., Hardin, J. W., Perez-Hernandez, R., & Froeliger, B. (2016). Depressive symptoms and responses to cigarette pack warning labels among Mexican smokers. Health Psychology, 35, 442–453. doi:10.1037/hea0000298 CrossRefPubMedPubMedCentralGoogle Scholar
  74. Perez, C. M., Ledbetter, A. D., Hazari, M. S., Haykal-Coates, N., Carll, A. P., Winsett, D. W., et al. (2013). Hypoxia stress test reveals exaggerated cardiovascular effects in hypertensive rats after exposure to the air pollutant acrolein. Toxicological Sciences, 132(2), 467–477.CrossRefPubMedPubMedCentralGoogle Scholar
  75. Pfeifer, G. P., Denissenko, M. F., Olivier, M., Tretyakova, N., Hecht, S. S., & Hainaut, P. (2002). Tobacco smoke carcinogens, DNA damage and p 53 mutations in smoking-associated cancers. Oncogene, 21, 7435–7451.CrossRefPubMedGoogle Scholar
  76. Reddy, P., Meyer-Weitz, A., & Yach, D. (1996). Smoking status, knowledge of health effects and attitudes towards tobacco control in South Africa. South African Medical Journal, 86, 1389–1393.PubMedGoogle Scholar
  77. Rodgman, A., & Perfetti, T. A. (2013). The chemical components of tobacco and tobacco smoke (2nd ed.). New York: CRC Press.CrossRefGoogle Scholar
  78. Schmeltz, I., & Hoffmann, D. (1977). Nitrogen-containing compounds in tobacco and tobacco smoke. Chemical Reviews, 77, 295–311.CrossRefGoogle Scholar
  79. Siahpush, M., McNeill, A., Hammond, D., & Fong, G. (2006). Socioeconomic and country variations in knowledge of health risks of tobacco smoking and toxic constituents of smoke: Results from the 2002 International Tobacco Control (ITC) Four Country Survey. Tobacco Control, 15, iii65–iii70.PubMedPubMedCentralGoogle Scholar
  80. Stea, F., Bianchi, F., Cori, L., & Sicari, R. (2014). Cardiovascular effects of arsenic: Clinical and epidemiological findings. Environmental Science and Pollution Research, 21, 244–251. doi:10.1007/s11356-013-2113-z CrossRefPubMedGoogle Scholar
  81. Swayampakala, K., Thrasher, J. F., Hammond, D., Yong, H. H., Bansal-Travers, M., Krugman, D., et al. (2015). Pictorial health warning label content and smokers’ understanding of smoking-related risks-a cross-country comparison. Health Education Research, 30, 35–45. doi:10.1093/her/cyu022 CrossRefPubMedGoogle Scholar
  82. The European Parliment and the Council of the Eurpoean Union. (2014). Revision of the Tobacco Products Directive. Official Journal of the European Union. doi:http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf
  83. Thrasher, J. F., Huang, L., Pérez-Hernández, R., Niederdeppe, J., Arillo-Santillán, E., & Alday, J. (2011). Evaluation of a social marketing campaign to support Mexico City’s comprehensive smoke-free law. American Journal of Public Health, 101, 328–335. doi:10.2105/ajph.2009.189704 CrossRefPubMedPubMedCentralGoogle Scholar
  84. Thrasher, J. F., Murukutla, N., Pérez-Hernández, R., Alday, J., Arillo-Santillán, E., Cedillo, C., et al. (2013). Linking mass media campaigns to pictorial warning labels on cigarette packages: A cross-sectional study to evaluate effects among Mexican smokers. Tobacco Control, 22, e57–e65. doi:10.1136/tobaccocontrol-2011-050282 CrossRefPubMedGoogle Scholar
  85. U.S. Department of Health and Human Services. (2001). Hazardous substances data bank (HSDB online database). Retrieved from http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB
  86. U.S. Department of Health and Human Services. (2004). Toxicological profile for ammonia. Public Health Service Agency for Toxic Substances and Disease Registry. http://wwwatsdr.cdc.gov/toxprofiles/tp126.pdf
  87. U.S. Department of Health and Human Services. (2010). How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General. Atlanta, GA: US.Google Scholar
  88. U.S. Department of Health and Human Services. (2014). The health consequences of smoking—50 years of progress: A report of the Surgeon General. Rockville, MD: US.Google Scholar
  89. U.S. Food and Drug Administration. (2012). Harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. Federal Register, 77, 20034–20037.Google Scholar
  90. U.S. Food and Drug Administration. (2015). FDA takes action against three tobacco manufacturers for making “additive-free” and/or “natural” claims on cigarette labeling. [Press release]. Retrieved from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm459840.htm
  91. U.S. Food and Drug Administration. (2016a). Major activities table. Retrieved from http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/BudgetReports/UCM437623.pdf
  92. U.S. Food and Drug Administration. (2016b). Research priorities. Retrieved from http://www.fda.gov/TobaccoProducts/PublicHealthScienceResearch/Research/ucm311860.htm
  93. WHO Working Group. (2014). Partial guidelines for implementation of the Articles 9 and 10 of the WHO framework convention on tobacco control (regulation of the content of tobacco products and regulation of tobacco product disclosures). Geneva, SwitzerlandGoogle Scholar
  94. Wikmans, T., & Ramström, L. (2010). Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish Snus. Tobacco Induced Diseases, 8, 1. doi:10.1186/1617-9625-8-9 CrossRefGoogle Scholar
  95. Willems, E. W., Rambali, B., Vleeming, W., Opperhuizen, A., & van Amsterdam, J. G. (2006). Significance of ammonium compounds on nicotine exposure to cigarette smokers. Food and Chemical Toxicology, 44, 678–688. doi:10.1016/j.fct.2005.09.007 CrossRefPubMedGoogle Scholar
  96. Wiseman, K. D., Cornacchione, J., Wagoner, K. G., Noar, S. M., Moracco, K. E., Teal, R., et al. (2016). Adolescents’ and young adults’ knowledge and beliefs about constituents in novel tobacco products. Nicotine & Tobacco Research. doi:10.1093/ntr/ntw009 Google Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Jennifer C. Morgan
    • 1
    • 2
  • M. Justin Byron
    • 1
    • 2
  • Sabeeh A. Baig
    • 1
    • 2
  • Irina Stepanov
    • 3
  • Noel T. Brewer
    • 1
    • 2
  1. 1.Department of Health Behavior, Gillings School of Global Public HealthUniversity of North CarolinaChapel HillUSA
  2. 2.Lineberger Comprehensive Cancer CenterUniversity of North CarolinaChapel HillUSA
  3. 3.Division of Environmental Health Sciences, School of Public HealthUniversity of MinnesotaMinneapolisUSA

Personalised recommendations